|
Post by lakers on Nov 20, 2015 13:20:16 GMT -5
Please do not lock this thread which is created b/c the following thread was locked. 3Q15 ER Mon 11/9/15; BoD to convene Nov 2nd half to decide created Oct 29, 2015 at 1:43pm mnkd.proboards.com/thread/3875/3q15-mon-convene-half-decide?page=5Hakan 3Q15 CC 11/9/15: Negotiating with many for TS partnership- Will have partner by end of year The 50M Mnkd Shares TASE index funds got is such a sweet deal. Al'd rather offer to them than Sny. He really plays hard ball w/ Sny who must be really stingy. lakers... so is the result of the BOD meeting what you expected or a surprise? Might a TS partnership deal falling through been the proximate cause of a change of leadership? "Pain/Migraine partnership is being discussed as one of topics". Hakan has been on the rock..., not a surprise here. This indeed verifies that there has been a BoD meeting. Any doubter here ? Far from what you surmised, What would be better than letting the ultimate majority shareholder negotiate directly ? Better yet, Ask yourself, would you rather have someone else negotiate the fate of the company, of his own baby ? Al certainly lends gravity to the negotiation.
|
|
|
Post by bradleysbest on Nov 20, 2015 13:26:42 GMT -5
Agree & hope Al is the one negotiating! Thx!
|
|
|
Post by roseylv on Nov 20, 2015 13:35:13 GMT -5
Thanks Lakers for your contributions! Only cool update I have is a BoD member over at EYES is still a buyer of MNKD. Perhaps he / she has a bit more insight into the ongoings of MNKD then most of us retailers. I've been long for years and was bullish before I got that tidbit of info but it reaffirmed my bullishness.
I've got a feeling Al is recruiting a big name to take over so that he can sleep easy. Go get em Al, go get em!!!
|
|
|
Post by lakers on Nov 20, 2015 14:03:33 GMT -5
Thanks Lakers for your contributions! Only cool update I have is a BoD member over at EYES is still a buyer of MNKD. Perhaps he / she has a bit more insight into the ongoings of MNKD then most of us retailers. I've been long for years and was bullish before I got that tidbit of info but it reaffirmed my bullishness. I've got a feeling Al is recruiting a big name to take over so that he can sleep easy. Go get em Al, go get em!!! Do you think Dr. Shannon qualifies as Mnkd's CEO ? Lets vote! James S. Shannon Rejoins MannKind's Board of Directors VALENCIA, Calif., May 21, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that James S. Shannon, MD, MRCP (UK) has been elected to the company's Board of Directors after previously serving as a director from February 2010 until April 2012. The addition of Dr. Shannon brings the total number of MannKind Board members to eight. From May 2012 until his retirement in April 2015, Dr. Shannon was the Chief Medical Officer of GlaxoSmithKline. He formerly held the position of Global Head of Pharma Development at Novartis AG, based in Basel, Switzerland from 2005 until 2008. After joining Sandoz in 1994 as Head of Drug Regulatory Affairs, Dr. Shannon led of the Integration Office for R&D overseeing the creation of the Novartis R&D groups from those of Ciba-Geigy Ltd and Sandoz. Following the merger he was appointed Head of the Cardiovascular Strategic Team and subsequently became Global Head of Project Management before being appointed Global Head of Clinical Development and Medical Affairs in 1999, a position that he held until 2005 when he was appointed to Head Pharma Development. Between 2008 and joining GSK, Dr. Shannon served on the boards of a number of companies, including Biotie, Circassia, Crucell, Endocyte and MannKind. He also sat on the board of Cerimon Pharmaceuticals where he held the position of interim Chief Executive Officer and President from January 2009 until April 2010. He first entered the pharmaceutical industry in 1987 joining Sterling Winthrop Inc., working initially in Europe and subsequently in the USA, where he held positions of increasing responsibility in the management of research and development ultimately serving as Senior Vice-President, Clinical Development. Dr. Shannon is trained in Medicine and Cardiology. He received his undergraduate and postgraduate degrees at Queen's University of Belfast and is a Member of the Royal College of Physicians (UK). "We are very pleased to welcome James back to the board of directors," stated Alfred Mann, Executive Chairman of MannKind Corporation. "His experience as a recognized pharmaceutical industry leader is invaluable to us as we accelerate the commercialization of Afrezza® and build a pipeline of additional product opportunities that utilize our proprietary technologies."
|
|
|
Post by benyiju on Nov 20, 2015 14:23:32 GMT -5
This application (case file #002506) is not the same case file as was previously being discussed. If you read the information on the link provided (above) you'll find the following:
On 15 November 2012, Marvel LifeSciences Ltd officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Solumarv, intended for the treatment of patients with diabetes who require insulin to control their blood glucose.
Sorry... but this is not the mystery insulin we're wanting to find out about. No, mnholdem, you're wrong about this. The news is pretty clear at EMA website. Read for yourself: www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/11/news_detail_002432.jsp&mid=WC0b01ac058004d5c1
|
|
|
Post by dreamboatcruise on Nov 20, 2015 14:39:09 GMT -5
lakers... so is the result of the BOD meeting what you expected or a surprise? Might a TS partnership deal falling through been the proximate cause of a change of leadership? "Pain/Migraine partnership is being discussed as one of topics". Hakan has been on the rock..., not a surprise here. This indeed verifies that there has been a BoD meeting. Any doubter here ? Far from what you surmised, What would be better than letting the ultimate majority shareholder negotiate directly ? Better yet, Ask yourself, would you rather have someone else negotiate the fate of the company, of his own baby ? Al certainly lends gravity to the negotiation. Your previous posts (and thread title) indicate not just a discussion but a decision at this BOD meeting. My surmising regarding it falling through was simply based on you setting up the expectation of a decision and now the apparent lack of one. I would find it difficult to believe they wouldn't have held off on the Hakan announcement if they were still convened and likely to approve a TS deal as well.
|
|
|
Post by mnholdem on Nov 20, 2015 14:50:54 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 20, 2015 15:39:40 GMT -5
why are we going offtopic on EMA approval in this? smh
|
|
|
Post by mnholdem on Nov 20, 2015 16:19:04 GMT -5
Just wrapping up earlier speculation that EMA approval would be on the BoD meeting agenda.
|
|
|
Post by gamblerjag on Nov 28, 2015 21:36:38 GMT -5
Has anyone acknowledged that Lakers was 3/3 in the month of November including the big news with CEO shakeup. I'm not sure if that was what Laker's was referring to but he did say BoD would have some big news (sorry off memory) 2nd half of November. Hopefully we will again get some accurate insight but in the positive direction.
|
|
|
Post by dreamboatcruise on Nov 28, 2015 22:12:01 GMT -5
Has anyone acknowledged that Lakers was 3/3 in the month of November including the big news with CEO shakeup. I'm not sure if that was what Laker's was referring to but he did say BoD would have some big news (sorry off memory) 2nd half of November. Hopefully we will again get some accurate insight but in the positive direction. Check the title of the thread. There was not a prediction of CEO leaving, it was a TS "partnership".
|
|
|
Post by jeremg on Nov 28, 2015 22:16:55 GMT -5
Has anyone acknowledged that Lakers was 3/3 in the month of November including the big news with CEO shakeup. I'm not sure if that was what Laker's was referring to but he did say BoD would have some big news (sorry off memory) 2nd half of November. Hopefully we will again get some accurate insight but in the positive direction. Check the title of the thread. There was not a prediction of CEO leaving, it was a TS "partnership". Lakers crystal ball was on the fritz the week Hakan "resigned". Can't expect the guy to be right everytime, even if he is on the "inside".
|
|
|
Post by gamblerjag on Nov 28, 2015 22:46:03 GMT -5
I think that was the second thread. His first was believe in late Oct. re: November 9th would be earcings release/ CC and then mentioned about news the second half of November for some other news. I don't recall or think he said Techno news on the first thread.
|
|
|
Post by sportsrancho on Nov 29, 2015 7:56:53 GMT -5
I think that was the second thread. His first was believe in late Oct. re: November 9th would be earcings release/ CC and then mentioned about news the second half of November for some other news. I don't recall or think he said Techno news on the first thread. Right, he said they were meeting to make a important decision. Did not sound like it was about TS.
|
|
|
Post by dreamboatcruise on Nov 29, 2015 12:52:02 GMT -5
I think that was the second thread. His first was believe in late Oct. re: November 9th would be earcings release/ CC and then mentioned about news the second half of November for some other news. I don't recall or think he said Techno news on the first thread. Right, he said they were meeting to make a important decision. Did not sound like it was about TS. It would be good if he were a bit less cryptic. I have asked him to provide clarification about what it was he was predicting. That is in this thread. It appears that he isn't claiming that he knew Hakan was leaving. Perhaps he just knew there would be a BOD meeting but had no info on what it would be about. Speculation regarding it being TS partnership was running rampant before the BOD, so it would have been nice if he'd been clear that he had no info to indicate that is what was afoot.
|
|